<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>19</Volume>
      <Issue>S1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2020</Year>
        <Month>05</Month>
        <Day>17</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Crocus Sativus (Saffron): An Immunoregulatory Factor in the Autoimmune and Non-autoimmune Diseases</title>
    <FirstPage>27</FirstPage>
    <LastPage>42</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Javad</FirstName>
        <LastName>Poursamimi</LastName>
        <affiliation locale="en_US">Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran AND Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Zhaleh</FirstName>
        <LastName>Shariati-Sarabi</LastName>
        <affiliation locale="en_US">Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran AND Department of Internal Medicine, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Jalil</FirstName>
        <LastName>Tavakkol-Afshari</LastName>
        <affiliation locale="en_US">Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Ahmad</FirstName>
        <LastName>Mohajeri</LastName>
        <affiliation locale="en_US">Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University  of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mojgan</FirstName>
        <LastName>Mohammadi</LastName>
        <affiliation locale="en_US">Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran AND Department of Immunology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2019</Year>
        <Month>11</Month>
        <Day>05</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2019</Year>
        <Month>12</Month>
        <Day>06</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">It has been reported that patients with arthritis, osteoarthritis, atherosclerosis, coronary artery disease, brain ischemia, diabetes, and inflammatory bowel disease (IBD) suffer from pro-inflammatory and oxidant related responses. Therefore, anti-inflammatory and anti-oxidant therapies are used to improve the quality of life of the patients. Saffron is a herbal drug that has immunomodulatory and antioxidant properties. Hence, Saffron and its components have been proposed as therapeutic agents for the treatment of the diseases. Therefore, this review article was designed to collect recent information regarding the effects of saffron and its components on the amelioration of the inflammatory symptoms in the autoimmune and non-autoimmune diseases and anti-cancerous effects from 1999 up to now via searching the Pubmed, Google Scholar, and Scopus databases. Due to fact that several investigations have reviewed the roles played by Saffron on autoimmune and non-autoimmune diseases such as multiple sclerosis, mood disorders, and Alzheimer's disease, this review article focuses on other diseases to keep the novelty of the present review for readers.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/2586</web_url>
  </Article>
</Articles>
